Skip to main content
Clinical Trials/CTRI/2023/01/048654
CTRI/2023/01/048654
Recruiting
Phase 3

Evaluation of comparative efficacy of Intralesional Apamarga Ksharodak versus Intralesional Cidofovir in the management of Charmakeela(Warts)

Datta Meghe Institute of Medical Science0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Sponsor
Datta Meghe Institute of Medical Science
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Datta Meghe Institute of Medical Science

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient willing with written informed consent as per Helsinki declaration.
  • 2\. Age group of 17 to 70 years.
  • 3\. Patients with clinical features of warts of painless , small ,rough and hard growth similar to skin .
  • 4\. Patients irrespective of gender, occupation and economic status.

Exclusion Criteria

  • 1\. Uncontrolled and insulin dependent Diabetes Mellitus, Uncontrolled Hypertension , Tuberculosis, Carcinoma , Endocrine Disorders and Kidney or hepatic disorder.
  • 2\. Sites of warts â?? sensitive places like : genitals, eye lids, lips, etc .
  • 3\. History of anticoagulants and haemophilla.
  • 4\. Pregnant and lactating females.
  • 5\. Substantial abnormalities in hematological

Outcomes

Primary Outcomes

Not specified

Similar Trials